Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin

Journal of Pathology

Volumn 183, Issue 3, 1997, Pages 264-271

  Andriessen, Monique P ^a   Van Den Born, Jaap ^a   Latijnhouwers, Mieke A ^a   Bergers, Mieke ^a   Van De Kerkhof, Peter C ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Basal membrane; Epidermal proliferation; Heparan sulphate; Human skin; Immunohistochemistry; Proteoglycan; Wound healing

Indexed keywords

EPITOPE; GROWTH FACTOR; HEPARAN SULFATE; LAMININ; MONOCLONAL ANTIBODY; PROTEOHEPARAN SULFATE;

ADULT; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL PROLIFERATION; DERMOEPIDERMAL JUNCTION; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; WOUND HEALING;

ADULT; BASEMENT MEMBRANE; CELL DIVISION; EPIDERMIS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; PERMEABILITY; SKIN; WOUND HEALING;

EID: 0030665450     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199711)183:3<264::AID-PATH940>3.0.CO;2-3     Document Type: Article

References (40)

1. Ruoslahti E. Structure and biology of proteoglycans. Annu Rev Cell Biol 1988; 4: 229-255.
2. Wight TN, Heinegard DK. Hascall VC. Proteoglycans. structure and function. In: Hay ED. ed. Cell Biology of Extracellular Matrix. New York: Plenum Press, 1991; 45-78.
3. Templeton DM. Proteoglycans in cell regulation. Crit Rev Clin Lab Sci 1992; 29: 141-184.
4. Noonan DM, Fulle A, Valente P, et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991; 266: 22939-22947.
5. Bernfield M, Kokenyesi R, Kato M. et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8: MB.
6. Kugelman LC, Ganguly S, Haggerty JG, Weissman SM. Milstone LM. The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD 44. [Corrected and republished article originally printed in J Invest Dermatol 1992, 99: 381-385.] J Invest Dermatol 1992: 99: 886-891.
7. Kanwar YS, Linker A, Farquhar MG. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 1980; 86: 688-693.
8. van den Born J, van den Heuvel LP, Bakker MA, et al. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 1993: 43: 454-463.
9. Ruoslahti E, Yamaeuchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-869.
10. Heremans A, De Cock B, Cassiman JJ, Van den Berghe H, David G. The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin. J Biol Chem 1990; 265: 8716-8724.
11. Grant DS, Leblond CP, Kleinman HK, Inoue S, Hassell JR. The incubation of laminin, collagen IV, and heparan sulfate proteoglycan at 35 degrees C yields basement membrane-like structures. J Cell Biol 1989; 108: 1567-1574.
12. Picker LJ, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 1989; 109: 927-937.
13. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990; 38: 1549-1563.
14. Schalkwijk J, Van Vlijmen I, Oosterling B. et al. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991; 124: 13-20
15. Murdoch AD, Liu B, Schwarting R, Tuan RS, lozzo RV. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 1994; 42: 239-249.
16. Latijnhouwers MA, Bergers M, van Bergen BH, Spruijt KI, Andriessen MPM, Scbalkwijk J. Tenascin expression during wound healing in human skin. J Pathol 1996; 178: 30-35.
17. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem 1994; 42: 89-102.
18. van den Born J, Gunnarsson K, Bakker MAH, et al. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 1995; 270: 31303-31309.
19. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. Lab Invest 1991; 65: 287-297.
20. van den Heuvel LP, van den Born J, Veerkamp JH, et al. Heparan sulfate proteoglycan from human tubular basement membrane. Comparison with this component from the glomerular basement membrane. Biochem Biophys Acta 1990; 1025: 67-76.
21. Hagen SG, Michael AF, Butkowski RJ. Immunochemical and biochemical evidence for distinct basement membrane heparan sulfate proteoglycans. J Biol Chem 1993; 268: 7261-7269.
22. Tsen G, Halfter W, Kroger S, Cole GJ. Agrin is a heparan sulfate proteoglycan. J Biol Chem 1995; 270: 3392-3399.
23. Denzer A, Gesemann M, Schumacher B, Ruegg A, An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. J Cell Biol 1995; 270: 3392-3399 (Abstract).
24. Andriessen MPM, van Bergen BH, Spruijt KIJ, Go IH, Schalkwijk J, van de Kerkhof PCM. Epidermal proliferation is not impaired in chronic venous ulcers. Acta Derm Venereol Stockh 1996; 288: 458-462.
25. Verschoore M, Kowalewski C, Chorzelska MJ, Bernard BA, Darmon YM. Intraepidermal leakage of plasma proteins after tape stripping of normal skin and uninvolved psoriatic skin. Br J Dermatol 1990; 122: 391-397.
26. Yeo TK, Broun L, Dvorak HF. Alterations in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol 1991; 138: 1437-1450.
27. Oksala O, Salo T, Tammi R, et al. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem 1995; 43: 125-135.
28. Stanley JR, Alvarez OM, Bere EW Jr, Eaglstein WH, Katz SI. Detection of basement membrane zone antigens during epidermal wound healing in pigs. J Invest Dermatol 1981; 77: 240-243.
29. Mainardi CL, Dixit SN, Kang AH. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem 1980; 255: 5435-5441.
30. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988; 107: 2757-2767.
31. Whitby DJ, Longaker MT, Harrison MR, Adzick NS, Ferguson MW. Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin. J Cell Sci 1991; 99: 583-586.
32. Clark RA, Potential roles of fibronectin in cutaneous wound repair. Arch Dermatol 1988; 124: 201-206.
33. Compton CC, Gill JM, Bradford DA, Regauer S, Gallico GG, O'Connor NE. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. A light, electron microscopic and immunohistochemical study. Lab Invest 1989; 60: 600-612.
34. Martin P, Hopkinson Woolley J, McCluskey J. Growth factors and cutaneous wound repair. Prog Growth Factor Res 1992; 4: 25-44.
35. Kiritsy CP, Lynch AB, Lynch SE. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med 1993; 4: 729-760.
36. Schalkwijk J, Steijlen PM, van Vlijmen Willems IM, Oosterling B, Mackie EJ, Verstraeten AA. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991; 139: 1143-1150.
37. Vehaskari VM, Root ER, Germuth FG Jr, Robson AM. Glomerular charge and urinary protein excretion: effects of systemic and intrarenal polycation infusion in the rat. Kidney Int 1982; 22: 127-135.
38. Hunsicker LG, Shearer TP, Shaffer SJ. Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int 1981; 20: 7-17.
39. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992; 41: 115-123.
40. Turnbull JE, Gallagher JT. Heparan sulphate: functional role as a modulator of fibroblast growth factor activity. Biochem Soc Trans 1993; 21: 477-482.